Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly.
Target Acquisition Valued at $10 Million with Projected 2025 Gross Revenue of $5 Million, Positioning CBDL for Explosive Growth in Nevada's Burgeoning Cannabis Market
Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.
Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.
With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.
The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD 57.18 billion in 2023 to USD 444.34 billion by 2030, exhibiting a CAGR of 34.03% during the forecast...
CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.
The targeted acquisition is estimated to have a business value of approximately $10 million and projected 2024 gross revenues of up to $4.5 million
SCOTTSDALE, AZ / ACCESSWIRE / July 16, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its dynamic subsidiary The CBD Vault Inc, is thrilled to announce a transformative partnership with Sunset...